Pharmacokinetics and tolerability of different doses of fentanyl following sublingual administration of a rapidly dissolving tablet to cancer patients: A new approach to treatment of incident pain

British Journal of Clinical Pharmacology

Volumn 59, Issue 2, 2005, Pages 249-253

  Lennernas B ^a,b   Hedner, T ^c   Holmberg, M ^a,b   Bredenberg, S ^d   Nystrom C ^d   Lennernas H ^d  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Fentanyl; Incident pain; Pharmacokinetics; Sublingual administration

Indexed keywords

FENTANYL; OPIATE;

ADULT; AGED; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; CANCER; CANCER PAIN; CAUCASIAN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG SOLUBILITY; DRUG TOLERABILITY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METASTASIS; NAUSEA; PAIN; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TABLET FORMULATION; VOMITING;

ADMINISTRATION, SUBLINGUAL; ADULT; AGED; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; AREA UNDER CURVE; CROSS-SECTIONAL STUDIES; DOUBLE-BLIND METHOD; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN; TABLETS;

EID: 13444274550     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2004.02264.x     Document Type: Article

References (21)

1. McMillan C. Breakthrough pain: assessment and management in cancer patients. Br J Nurs 2001; 10 (13): 860-6.
2. Strang P. Cancer pain - a provoker of emotional, social and existential distress. Acta Oncol 1998; 37: 641-4.
3. Cherny N. New strategies in opioid therapy for cancer pain. J Oncol Manag 2000; 9: 8-15.
4. McQuay HJ, Jadad AR. Incident pain. Cancer Surv 1994; 21: 17-24.
5. Coluzzi PH, Schwartzberg L, Conroy JD, Charapata S, Gay M, Busch MA, Chavez J, Ashley J, Lebo D, McCracken M, Portenoy RK. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain 2001; 91: 123-30.
6. Boyle R, Behan PO, Sutton JA. A correlation between severity of migraine and delayed gastric emptying measured by an epigastric impedance method. Br J Clin Pharrnacol 1990; 30: 405-9.
7. Zhang H, Zhang J, Streisand JB. Oral mucosal delivery: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokin 2002; 41: 661-80.
8. Winiwarter S, Bonham N, Hallberg A, Lennernäs H, Karlén A. Correlation of human jejunal permeability (in vivo) with experimentally and theoretically derived parameters. A multivariate data analysis approach. J Med Chem 1999; 41: 4939-49.
9. Roy SD, Flynn GL. Solubility and related physicochemical properties of narcotic analgesics. Pharm Res 1988; 5: 580-6.
10. Dollery C, Fentanyl. In Dollery C (ed) 1991 Therapeutic drugs Volume 1. Churchill Linvingstone, Edinburgh, p F26-F29.
11. Gardner-Nix J. Oral transmucosal fentanyl and sufentanil for incident pain. J Pain Pain Manage 2001; 22: 627-30.
12. Labroo RB, Paine MF, Thummel KE, Kharasch ED. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy and drug interactions. Drug Metabolism Disposition 1997; 25: 1072-80.
13. Ozdemir V, Kalowa W, Tang BK, Paterson AD, Walker SE, Endrenyi L, Kashuba AD. Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. Pharmacogenetics 2000; 10: 373-88.
14. Sundell-Bredenberg S, Nyström C. The possibility of achieving an interactive mixture with high dose homogeneity containing an extremely low proportion of a micronised drug. Eur J Pharm Sci 2001; 12: 285-95.
15. Dale O, Hjortkjaer R, Kharasch ED. Nasal administration of opioids for pain management in adults. Acta Anaesthesiol Scand 2002; 46: 759-70.
16. Streisand JB, Busch MA, Egan TD, Smith BG, Gay M, Pace NL. Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate. Anesthesiol 1998; 88: 305-9.
17. Roy SD, Flynn GL. Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm Res 1989; 6: 825-32.
18. Poyhia R, Seppala T. Liposolubility and protein binding of oxycodone in vitro. Pharmacol Toxicol 1994; 74: 23-7.
19. Gupta SK, Sathyan G, Phipps B, Klausner M, Southarn M. Reproducible fentanyl doses delivered intermittently at different time intervals from an electrotransport system. J Pharm Sci 1999; 88 (8): 835-41.
20. Andrews C, Prys Roberts C. Fentanyl - a review. Clin Anesth 1983; 1: 97-122.
21. Mather LE, Woodhouse A, Ward ME, Farr SJ, Rubsamen RA, Eltherington LG. Pulmonary administration of aerosolised fentanyl: pharmacokinetic analysis of systemic delivery. Br J Clin Pharmacol 1998; 46: 37-43.